Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.Rev Med Virol. 2020 Sep; 30(5):e2122.RM
Abstract
Coronavirus (CoV) disease 2019 (COVID-19) is an ongoing pandemic caused by severe acute respiratory syndrome CoV 2 (SARS-CoV-2). The highly contagious SARS-CoV-2 belongs to the genus Betacoronavirus, and it is phylogenetically closely related to SARS-CoV, a human CoV that caused an outbreak back in 2002 to 2003. Both SARS-CoV-2 and SARS-CoV enter human cells via the interactions between viral crown-like spike protein and human angiotensin-converting enzyme 2 (ACE2) receptor. Here, we aim to review the involvement of ACE2 in human CoV infections by discussing the roles of ACE2 in CoV evolution, cross-species transmissibility, and COVID-19 susceptibility. We also provide our perspectives on COVID-19 treatment and prevention.
Links
MeSH
Angiotensin-Converting Enzyme 2AnimalsBetacoronavirusBiological EvolutionCOVID-19ChiropteraCoronavirus InfectionsEutheriaGene Expression RegulationHumansPandemicsPeptidyl-Dipeptidase APhylogenyPneumonia, ViralProtein BindingReceptors, VirusSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSpike Glycoprotein, CoronavirusVirus Internalization
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
32602627
Citation
Tan, Heng Wee, et al. "Angiotensin-converting Enzyme 2: the Old Door for New Severe Acute Respiratory Syndrome Coronavirus 2 Infection." Reviews in Medical Virology, vol. 30, no. 5, 2020, pp. e2122.
Tan HW, Xu YM, Lau ATY. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Rev Med Virol. 2020;30(5):e2122.
Tan, H. W., Xu, Y. M., & Lau, A. T. Y. (2020). Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Reviews in Medical Virology, 30(5), e2122. https://doi.org/10.1002/rmv.2122
Tan HW, Xu YM, Lau ATY. Angiotensin-converting Enzyme 2: the Old Door for New Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Rev Med Virol. 2020;30(5):e2122. PubMed PMID: 32602627.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
AU - Tan,Heng Wee,
AU - Xu,Yan-Ming,
AU - Lau,Andy T Y,
Y1 - 2020/06/30/
PY - 2020/3/20/received
PY - 2020/4/30/revised
PY - 2020/5/4/accepted
PY - 2020/7/1/pubmed
PY - 2020/10/2/medline
PY - 2020/7/1/entrez
KW - ACE2
KW - COVID-19
KW - SARS-CoV-2
SP - e2122
EP - e2122
JF - Reviews in medical virology
JO - Rev Med Virol
VL - 30
IS - 5
N2 - Coronavirus (CoV) disease 2019 (COVID-19) is an ongoing pandemic caused by severe acute respiratory syndrome CoV 2 (SARS-CoV-2). The highly contagious SARS-CoV-2 belongs to the genus Betacoronavirus, and it is phylogenetically closely related to SARS-CoV, a human CoV that caused an outbreak back in 2002 to 2003. Both SARS-CoV-2 and SARS-CoV enter human cells via the interactions between viral crown-like spike protein and human angiotensin-converting enzyme 2 (ACE2) receptor. Here, we aim to review the involvement of ACE2 in human CoV infections by discussing the roles of ACE2 in CoV evolution, cross-species transmissibility, and COVID-19 susceptibility. We also provide our perspectives on COVID-19 treatment and prevention.
SN - 1099-1654
UR - https://www.unboundmedicine.com/medline/citation/32602627/Angiotensin_converting_enzyme_2:_The_old_door_for_new_severe_acute_respiratory_syndrome_coronavirus_2_infection_
DB - PRIME
DP - Unbound Medicine
ER -